![Gerhard Wolff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Storia della carriera di Gerhard Wolff
Precedenti posizioni note di Gerhard Wolff
Società | Posizione | Inizio | Fine |
---|---|---|---|
National Institute of Health Policy | Corporate Officer/Principal | - | - |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | Corporate Officer/Principal | - | - |
Revotar Biopharmaceuticals AG
![]() Revotar Biopharmaceuticals AG Pharmaceuticals: MajorHealth Technology Revotar Biopharmaceuticals AG specializes in the research and development of anti-inflammatory drugs. The firm develops drugs for the therapy and treatment of inflammatory disorders such as psoriasis, asthma and acute lung injuries, and chronic obstructive pulmonary diseases. Its focus areas include product licensing, drug discovery, and clinical development. The firm also engages in partnerships and projects with biotechnology research institutions and pharmaceutical enterprises. The company was founded in August 2000 and is headquartered in Hennigsdorf, Germany. | Corporate Officer/Principal | 20/12/2005 | - |
Formazione di Gerhard Wolff
Universität Leipzig | Doctorate Degree |
Statistiche
Distribuzione geografica
Germania | 3 |
Stati Uniti | 3 |
Posizioni
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Revotar Biopharmaceuticals AG
![]() Revotar Biopharmaceuticals AG Pharmaceuticals: MajorHealth Technology Revotar Biopharmaceuticals AG specializes in the research and development of anti-inflammatory drugs. The firm develops drugs for the therapy and treatment of inflammatory disorders such as psoriasis, asthma and acute lung injuries, and chronic obstructive pulmonary diseases. Its focus areas include product licensing, drug discovery, and clinical development. The firm also engages in partnerships and projects with biotechnology research institutions and pharmaceutical enterprises. The company was founded in August 2000 and is headquartered in Hennigsdorf, Germany. | Health Technology |
National Institute of Health Policy |
- Borsa valori
- Insiders
- Gerhard Wolff
- Esperienza